CBS Renews 18 Shows Including MacGyver and Mom and Blue Bloods
CBS announced this morning that it is renewing 18 shows, including six comedies, nine dramas, one reality series, two news magazines and a number of successful comedies. The network renewals include the #1 scripted program/comedy The Big Bang Theory, the #1 drama NCIS, the #1 new series Bull the #1 new comedy Kevin Can Wait and the #1 newsmagazine 60 Minutes. Renewals also include the comedy Mom, for which star Allison Janney won the Primetime Emmy Award for Outstanding Supporting Actress in a Comedy Series in 2014 and 2015.
The network announced that there are five freshman shows in the list of CBS’ early renewals including Bull, MacGyver, Man With a Plan and Superior Donuts.
Here is the full list of renewed series to date for the 2017-2018 season:
- The Big Bang Theory
- Blue Bloods
- Bull
- Hawaii Five-O
- Kevin Can Wait
- Life in Pieces
- MacGyver
- Madam Secretary
- Man With a Plan
- Mom
- NCIS
- NCIS: Los Angeles
- NCIS: New Orleans
- Scorpion
- Superior Donuts
- Survivor
- 48 Hours
- 60 Minutes
CBS will finish the current season as America’s Most Watched Network for the 14th time in 15 years. The Network will announce its new fall 2017-2018 schedule on Wednesday, May 17 at Carnegie Hall in New York City.
The Mom renewal is for the show’s fifth season. The show also stars Anna Faris. The Big Bang Theory, who’s renewal was recently announced, was renewed for two seasons, its 11th and 12th. That show is also getting a spinoff, showing the life of a young Sheldon Cooper (Jim Parsons) and his family in his home state of Texas. NCIS is the second longest-running scripted, non-animated U.S. primetime TV series currently airing, and was renewed for its 15th season.
So, which shows are you most excited to see return to CBS? Are you a fan of The Big Bang Theory? Mom? Have you been watching NCIS since the beginning? We want to hear from you. Leave us your comments or tweet us @ComingSoonnet.
The post CBS Renews 18 Shows Including MacGyver and Mom appeared first on ComingSoon.net.
0 comments: